Corporate Tech Investors

Amunix

Amunix is a corporate VC investing group that partners with technologies that align with its strategic interests.

Venture Investor Overview

Contact Information

Background Information

Overview

Amunix was founded in 2006 by Willem 'Pim' Stemmer and Volker Schellenberger. It has now grown to encompass 30 employees, a dedicated in-house patent attorney, and over 12,000 square feet of research labs. Our primary focus continues to be the design and preclinical development of protein pharmaceuticals with extended serum half-lives through the application of our XTEN technology platform. Central to our platform, XTEN is a hydrophilic, unstructured polypeptide which imparts a number of favorable properties to the molecules to which it has been fused.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

10/8/2013

Transaction History

Our records indicate that Amunix invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Angie You

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Amunix has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

AmTrust | Amylin Pharmaceuticals

Share this article

About Our Corporate Tech Investing Database

This corporate tech investor profile is powered by VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary